// App-Quantinova.ai

4369 : Preclinical mechanistic PK/PD-efficacy modeling for AZD9833, a novel next generation oral SERD, to support dose selection during early clinical development

Researchers

Presenter

  • Pablo Morentin Gutierrez

Principal Investigators

  • Christopher Morrow

  • Natalie Cureton

  • Mandy Lawson

  • Dawn Trueman

  • Eric Gangl

  • Joanne Wilson

  • Aaron Smith

  • James Scott

  • Teresa Klinowska

Medical Centers

  • AstraZeneca, Waltham, MA

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Progesterone receptor

  • Estrogen Receptor 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Pharmacokinetics

  • Pharmacodynamics

Phase

  • NA

Study Id's

  • NCT03616587

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved